Defunct Company
Total Trials
6
As Lead Sponsor
2
As Collaborator
4
Total Enrollment
1,126
NCT00702754
An Open Label Safety and Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) Injectable Solution in Patients With Cervical Dystonia
Phase: Phase 4
Role: Lead Sponsor
Start: Jun 30, 2001
Completion: Sep 30, 2008
NCT00208091
Quantifying Musical Performance After Treatment With Myobloc in Musician's Dystonia
Role: Collaborator
Start: Apr 30, 2003
Completion: May 31, 2008
NCT00515437
A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients
Phase: Phase 2
Start: Jul 31, 2007
NCT02052024
Myobloc Atrophy Study
Start: May 31, 2014
Completion: Aug 31, 2015
NCT04099667
Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity
Phase: Phase 2/3
Start: Dec 17, 2019
Completion: Jul 31, 2024
NCT04815967
Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity
Start: Nov 16, 2021
Completion: Jul 1, 2024